Charles River Laboratories | CRL - 負債





負債 変化する 日付
Agilent USD 3.36B 1000K 2026-03
Align Technology USD 116.04M 1.6M 2026-03
Bio-Rad Laboratories USD 1.37B 7.8M 2026-06
Bruker USD 1.82B 153.5M 2026-06
Cardinal Health USD 8.89B 30M 2026-06
Charles River Laboratories USD 3.06B 485.84M 2026-03
Cigna USD 30.9B 563M 2026-03
Concord Medical Services Hldg CNY 3.01B 27.15M 2023-06
CVS Health USD 61.41B 16.94B 2026-06
Danaher USD 26.56B 8.07B 2026-06
Dentsply International USD 2.33B 137M 2026-03
Elevance Health USD 31.04B 798M 2026-06
Humana USD 14.25B 254M 2026-06
Illumina USD 2.54B 9M 2026-03
Incyte USD 38.27M 1.16M 2026-06
Intrexon USD 0 13.82M 2024-06
IQVIA Holdings USD 16.24B 408M 2026-06
Laboratory Of America USD 7.24B 714.6M 2026-03
Lakefront Biotherapeutics EUR 6.44M 480K 2026-03
Lonza CHF 4.71B 915M 2024-12
McKesson USD 8.61B 10M 2026-03
Merck EUR 12.04B 86M 2026-03
Mettler Toledo International USD 2.23B 76.47M 2026-03
Novartis USD 49.01B 2.02B 2026-06
Pfizer USD 63.19B 536M 2026-06
Quest Diagnostics USD 6.41B 179M 2026-03
Revvity USD 3.35B 48.03M 2026-03
Thermo Fisher Scientific USD 43.16B 3.78B 2026-03
United Therapeutics USD 200M 100M 2025-03
UnitedHealth USD 73.33B 4.59B 2026-06
Veradigm USD 200.33M 431K 2022-09
Waters USD 5.57B 4.08B 2026-03
West Pharmaceutical Services USD 202.8M 0 2026-03